Figure 6 | Scientific Reports

Figure 6

From: Integrated single-cell and bulk RNA-seq analysis identifies a prognostic T-cell signature in colorectal cancer

Figure 6

TRGS predicts the sensitivity of fluorouracil-based ACT. (A, B) Kaplan–Meier curves comparing patients who received ACT with those who did not in TCGA (A) and GSE39582 (B) cohorts. (C, D) The predicted IC50 values of chemotherapy (C) and targeted therapy (D) drugs in different risk groups in the TCGA cohort. (E–H) Distribution of TRGS between responders and non-responders of fluorouracil-based ACT in TCGA (E), GSE28702 (F), GSE19860 (G), and GSE45404 (H) cohorts. (*P < 0.05, ** P < 0.01, *** P < 0.001).

Back to article page